Two-dose COVID-19 vaccination regimens do not elicit adequate neutralising antibodies against the Omicron coronavirus variant, according to British researchers, implying that higher infections in persons who have been infected or vaccinated are expected. On Monday, researchers from the University of Oxford revealed the findings of an unpublished investigation in which they analysed blood samples from participants in a big trial who were given dosages from AstraZeneca-Oxford or Pfizer-BioNTech.
The findings came only one day after British Prime Minister Boris Johnson warned that two vaccination doses would not be enough to prevent the Omicron form from spreading.
Recent Posts
Mounjaro Launched in India: Price & Impact on Diabetes and Obesity
Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…
Shocking Rabies Case in Greater Noida Challenges Common Misconceptions
A recent case of rabies transmission in Greater Noida has sent shockwaves through the community,…
Punjab Government to Ban Energy Drinks in Schools and Colleges for Student Health
The Punjab government is set to ban high-caffeine energy drinks in schools, citing severe health…
Experts Warn of Global Threat from Chronic Wasting Disease
Chronic Wasting Disease (CWD) is a highly contagious and fatal neurological disorder that affects deer,…
CDC Reschedules Vaccine Advisory Meeting to April 15-16
The Centers for Disease Control and Prevention (CDC) has announced a rescheduling of its vaccine…
India’s Specialty Chemicals Rebound, Pharma Exports Surge
India’s specialty chemicals industry and pharmaceutical exports continue to showcase resilience amid global uncertainties. As…